These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25120483)

  • 21. Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging.
    Chetelat G; Baron JC
    Neuroimage; 2003 Feb; 18(2):525-41. PubMed ID: 12595205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebral White Matter Lesions have Low Impact on Cognitive Function in a Large Elderly Memory Clinic Population.
    Claus JJ; Coenen M; Staekenborg SS; Schuur J; Tielkes CEM; Koster P; Scheltens P
    J Alzheimers Dis; 2018; 63(3):1129-1139. PubMed ID: 29710708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do white matter changes contribute to the subsequent development of dementia in patients with mild cognitive impairment? A longitudinal study.
    Wolf H; Ecke GM; Bettin S; Dietrich J; Gertz HJ
    Int J Geriatr Psychiatry; 2000 Sep; 15(9):803-12. PubMed ID: 10984726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of white matter hyperintensity measurements on brain MR imaging with cognitive status, medial temporal atrophy, and cardiovascular risk factors.
    Appel J; Potter E; Bhatia N; Shen Q; Zhao W; Greig MT; Raj A; Barker WW; Potter H; Schofield E; Wu Y; Loewenstein DA; Duara R
    AJNR Am J Neuroradiol; 2009 Nov; 30(10):1870-6. PubMed ID: 19643919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroticism, conscientiousness, and in vivo Alzheimer pathologies measured by amyloid PET and MRI.
    Byun MS; Jung JH; Sohn BK; Yi D; Lee JH; Jeon SY; Lee Y; Jung GJ; Lee JY; Kim YK; Shin SA; Sohn CH; Kang KM; Lee DY;
    Psychiatry Clin Neurosci; 2020 May; 74(5):303-310. PubMed ID: 31985106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebral white matter lesions in patients with dementia - from MCI to severe Alzheimer's disease.
    Targosz-Gajniak M; Siuda J; Ochudło S; Opala G
    J Neurol Sci; 2009 Aug; 283(1-2):79-82. PubMed ID: 19268974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease.
    Haris M; Yadav SK; Rizwan A; Singh A; Cai K; Kaura D; Wang E; Davatzikos C; Trojanowski JQ; Melhem ER; Marincola FM; Borthakur A
    Neuroimage Clin; 2015; 7():598-604. PubMed ID: 25844314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal global functional network connectivity and its relationship to medial temporal atrophy in patients with amnestic mild cognitive impairment.
    Sheng C; Xia M; Yu H; Huang Y; Lu Y; Liu F; He Y; Han Y
    PLoS One; 2017; 12(6):e0179823. PubMed ID: 28650994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progressive medial temporal lobe atrophy during preclinical Alzheimer's disease.
    Pettigrew C; Soldan A; Sloane K; Cai Q; Wang J; Wang MC; Moghekar A; Miller MI; Albert M;
    Neuroimage Clin; 2017; 16():439-446. PubMed ID: 28879085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRI of hippocampus and entorhinal cortex in mild cognitive impairment: a follow-up study.
    Tapiola T; Pennanen C; Tapiola M; Tervo S; Kivipelto M; Hänninen T; Pihlajamäki M; Laakso MP; Hallikainen M; Hämäläinen A; Vanhanen M; Helkala EL; Vanninen R; Nissinen A; Rossi R; Frisoni GB; Soininen H
    Neurobiol Aging; 2008 Jan; 29(1):31-8. PubMed ID: 17097769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Smell Identification Deficit with Alzheimer's Disease Assessment Scale-Cognitive Subscale, Japanese Version Scores and Brain Atrophy in Patients with Dementia.
    Yoshii F; Onaka H; Kohara S; Ryo M; Takahashi W
    Eur Neurol; 2019; 81(3-4):145-151. PubMed ID: 31242486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional White Matter Hyperintensity Influences Grey Matter Atrophy in Mild Cognitive Impairment.
    Vipin A; Foo HJL; Lim JKW; Chander RJ; Yong TT; Ng ASL; Hameed S; Ting SKS; Zhou J; Kandiah N
    J Alzheimers Dis; 2018; 66(2):533-549. PubMed ID: 30320575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure and function of medial temporal and posteromedial cortices in early Alzheimer's disease.
    Miettinen PS; Pihlajamäki M; Jauhiainen AM; Niskanen E; Hänninen T; Vanninen R; Soininen H
    Eur J Neurosci; 2011 Jul; 34(2):320-30. PubMed ID: 21692882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discriminating accuracy of medial temporal lobe volumetry and fMRI in mild cognitive impairment.
    Jauhiainen AM; Pihlajamäki M; Tervo S; Niskanen E; Tanila H; Hänninen T; Vanninen RL; Soininen H
    Hippocampus; 2009 Feb; 19(2):166-75. PubMed ID: 18777563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New MRI markers for Alzheimer's disease: a meta-analysis of diffusion tensor imaging and a comparison with medial temporal lobe measurements.
    Clerx L; Visser PJ; Verhey F; Aalten P
    J Alzheimers Dis; 2012; 29(2):405-29. PubMed ID: 22330833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease.
    Persson K; Barca ML; Eldholm RS; Cavallin L; Šaltytė Benth J; Selbæk G; Brækhus A; Saltvedt I; Engedal K
    Dement Geriatr Cogn Disord; 2017; 44(1-2):12-24. PubMed ID: 28614836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of atrophy differ among specific subtypes of mild cognitive impairment.
    Whitwell JL; Petersen RC; Negash S; Weigand SD; Kantarci K; Ivnik RJ; Knopman DS; Boeve BF; Smith GE; Jack CR
    Arch Neurol; 2007 Aug; 64(8):1130-8. PubMed ID: 17698703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease.
    Chincarini A; Bosco P; Calvini P; Gemme G; Esposito M; Olivieri C; Rei L; Squarcia S; Rodriguez G; Bellotti R; Cerello P; De Mitri I; Retico A; Nobili F;
    Neuroimage; 2011 Sep; 58(2):469-80. PubMed ID: 21718788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relations between personality changes and cerebrospinal fluid biomarkers of Alzheimer's disease pathology.
    Tautvydaitė D; Antonietti JP; Henry H; von Gunten A; Popp J
    J Psychiatr Res; 2017 Jul; 90():12-20. PubMed ID: 28213293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.